Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener Medizinische Wochenschrift 11-12/2018

Open Access 27.02.2018 | main topic

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

verfasst von: Clemens Röhrl, Herbert Stangl

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2018

Summary

Cholesterol is an essential lipid for mammalian cells and its homeostasis is tightly regulated. Disturbance of cellular cholesterol homeostasis is linked to atherosclerosis and cardiovascular diseases. A central role in the sensing and regulation of cholesterol homeostasis is attributed to the endoplasmic reticulum (ER). This organelle harbours inactive transcription factors, which sense ER cholesterol levels and initiate transcriptional responses after activation and translocation into the nucleus. Thereupon, these responses enable adaption to high or low cellular cholesterol levels. Besides the abovementioned canonical functions, ER stress—induced by metabolic burden—and the resulting unfolded protein response influence cholesterol metabolism relevant to metabolic disorders. This review summarizes basic as well as recent knowledge on the role of the ER in terms of regulation of cholesterol metabolism.

Cholesterol function and its role in atherosclerosis

Clinically, the most important plasma lipids are triglycerides and cholesterol. Apart from the central role of cholesterol in cellular organization and stability, it serves as a building block for steroid hormones, vitamin D, oxysterols and bile acids [1]. Its insolubility in plasma requires its transport in spherical macromolecules called lipoproteins, which consist of a hydrophobic core, containing mainly cholesteryl esters and triglycerides, and a hydrophilic coat consisting of phospholipids, free cholesterol and apolipoproteins. The major cholesterol-carrying lipoproteins are low-density lipoprotein (LDL; Table 1) and high-density lipoprotein (HDL) [1]. The clinical relevance of plasma lipid and lipoprotein levels for diagnosis and prognosis of diseases like atherosclerosis is generally accepted. An imbalance in cholesterol homeostasis is triggered by increased food intake or by genetic factors resulting in disposal of cholesterol in peripheral tissues, for instance the arterial wall. This can lead to atherosclerosis, vessel dysfunction and blocked blood flow, the underlying mechanism for cardiovascular diseases (CVDs). CVDs include stroke, heart attack and peripheral arterial disease (PAD) among others, and are still the number one killer in the westernized world [1].
Table 1
Selected factors implicated in cholesterol metabolism
Factor
Full name
Function
ABCA1
ATP binding cassette subfamily A member 1
Cholesterol export protein; key factor in HDL biogenesis
ABCG1
ATP binding cassette subfamily G member 1
Cholesterol export protein
ABCG5
ATP binding cassette subfamily G member 5
Biliary sterol exporter
ABCG8
ATP binding cassette subfamily G member 8
Biliary sterol exporter
Apo
Apolipoprotein
Structural component of lipoproteins; stabilizes lipoproteins and is an interaction partner for cellular receptors
ATF4
Activating transcription factor 4
Downstream signalling protein of the UPR; activated by PERK
ATF6
Activating transcription factor 6
Downstream signalling protein of the UPR; mediates transcription of chaperones
GRP78
Glucose-related protein 78
ER chaperone
HDL
High-density lipoprotein
Cholesterol transport vehicle; main factor in RCT; transports cholesterol to the liver and steroidogenic tissues
HMG-CoAR
3-hydroxy-3-methylglutaryl-CoA reductase
Rate-liming enzyme in cholesterol biosynthesis; target of statins
IDOL
Inducible degrader of the LDLR
Negative regulator of LDL uptake
INSIG
Insulin-induced gene
Blocks SREBP activation in response to high cellular cholesterol levels
IRE1
Inositol-requiring enzyme 1
Downstream signalling protein of the UPR; highly conserved among species
LDL
Low-density lipoprotein
Main cholesterol transport vehicle in humans
LDLR
Low-density lipoprotein receptor
Main receptor supplying cells with cholesterol
LXR
Liver X receptor
Positive regulator of cholesterol efflux and fatty acid synthesis
NRF1
Nuclear respiratory factor 1; official gene name: NFE2L1 (nuclear factor, erythroid 2 like 1)
Transcription factor which is activated in response to high cellular cholesterol levels; positive regulator of cholesterol efflux
PCSK9
Proprotein convertase subtilisin-like kexin type 9
Negative regulator of plasma LDL levels; mediates degradation of the LDLR
PERK
Protein kinase RNA-like ER kinase
Downstream signalling protein of the UPR; excess PERK-activation triggers apoptosis
RCT
Reverse cholesterol transport
Transport of excess peripheral cholesterol into the liver for disposal into the bile
S1P, S2P
Site- 1/2 protease
Golgi-resident proteases which activate transcription factors involved in cholesterol homeostasis (SREBP) and unfolded protein response (ATF6)
SCAP
SREBP cleavage-activating protein
Mediates transport of SREBP from the ER to the Golgi apparatus
SR-BI
Scavenger receptor class B member 1
HDL receptor
SREBP
Sterol regulatory element binding protein
Transcription factor which is activated in response to low cellular cholesterol levels; positive regulator of cholesterol uptake and synthesis
UPR
Unfolded protein response
Signalling cascade activated by ER stress; mediates adaptive mechanisms or apoptosis
Atherosclerosis is initiated by endothelium damage leading to the migration of monocytes into the intima and differentiation into macrophages. Macrophage scavenger receptors mediate excessive endocytosis of modified LDL, which lack negative feedback regulation and result in macrophage foam cell formation. The excessive uptake of modified LDL leads to cholesterol-induced apoptosis and inflammation. Cytokines produced by macrophages and endothelial cells stimulate smooth muscle cell proliferation. These early lesions are called fatty streaks and are precursors for advanced atherosclerotic lesions. The latter are characterized by a fibrous cap consisting of smooth muscle cells and extracellular matrix enclosing the lipid-enriched necrotic core. Non-resolved inflammation finally leads to plaque expansion, destabilization and rupture [2].
Taken together, cholesterol is an essential membrane constituent of mammalian cells; however, excess intracellular cholesterol can be toxic and leads to foam cell formation and cell stiffening, which in turn affects vascular integrity and cell signalling. Therefore, cells need to keep a tight balance between cholesterol synthesis, uptake and export, as cholesterol itself cannot be degraded in higher organisms. For cellular cholesterol efflux, cholesterol is transferred to HDL particles, which accept excess cholesterol mainly from peripheral cells and tissues for its transport back to the liver for concomitant disposal into the bile. This pathway is called reverse cholesterol transport (RCT). In contrast, circulating LDL particles, which are formed from triglyceride-rich lipoproteins after remodelling in the plasma and the liver, accomplish cholesterol transport to cells requiring lipids. In this case, cells express higher levels of the LDL-receptor (LDLR), a protein that mediates uptake of LDL particles via the classical receptor-mediated endocytosis pathway [3]. In case of total body cholesterol overloading, cholesterol will ultimately accumulate in LDL particles, which results in their prolonged circulation in the blood stream. This imbalance is consequently followed by oxidation of the particle itself, leading to increased atherosclerotic potential and stiffness of cell membranes. Indeed, oxidized LDL particles have been shown to induce endothelial stiffness [4]. The atherogenic process might, in turn, alter other transport processes, like HDL transcytosis over endothelial cells, which is crucial for lipid clearance in the intima. Over time, cholesterol and other lipids are deposited at the vessel wall, leading to plaque formation. However, the whole phenomenon starts at the cellular level when cells are confronted with cholesterol overload. Thus, understanding of the intracellular stress reactions triggered by cholesterol overload is necessary in order to undertake pharmacological counteractions.

Cellular cholesterol distribution and trafficking

Cholesterol is heterogeneously distributed throughout cellular membranes and organelles. It is enriched in the plasma membrane (PM), whereas endoplasmic reticulum (ER) cholesterol content is low. Specifically, cholesterol is 5–10-fold enriched in the PM compared to the ER. Cholesterol is also abundant in the endosomal recycling compartment (ERC), multivesicular bodies (MVBs), the trans-Golgi network and the Golgi apparatus [5]. Its heterogeneous distribution throughout cells is maintained to generate membrane properties compatible with the organelles’ distinct functions: Higher cholesterol concentrations contribute to increased membrane thickness and reduced permeability to small molecules, consistent with the barrier function of the plasma membrane. In contrast, low cholesterol concentrations in the ER are associated with increased membrane flexibility, enabling insertion and folding of proteins in its lipid bilayer [6].
Analysis of cholesterol’s subcellular localization had been hindered by the lack of methods to detect cholesterol in cells at high resolution. To overcome this obstacle and to visualize cellular cholesterol distribution by transmission electron microscopy at nanometre resolution, we—in collaboration with Adi Ellinger’s and Margit Pavelka’s group—made use of the development of novel fluorescent reporter probes mimicking cholesterol [7] in combination with methodological advances in photooxidation technology [8]. Using this method we were able to confirm and extend previous biochemical studies on the subcellular localization of cholesterol (Fig. 1; [9]).
The classical LDL-receptor pathway, which is well characterized by the seminal work of Brown and Goldstein, accounts for the majority of exogenous cholesterol delivery to most cell types [3]. In addition, HDL is an important source of cholesterol for specialized cell types such as cells involved in steroidogenesis [10].
LDL-receptor-bound LDL is internalized via clathrin-coated pits, which fuse with early sorting endosomes. Here, the LDL-receptor dissociates from its ligand as a result of decreased pH and then recycles back to the PM. Importantly, LDL-receptor recycling is inhibited by proprotein convertase subtilisin-like kexin type 9 (PCSK9), which is the target of the latest generation of cholesterol-lowering drugs [11]. The majority of LDL particles are further delivered to late endosomes followed by degradation of the particle and export of cholesterol. Intracellularly, cholesterol is transported via vesicular trafficking as well as non-vesicular carrier proteins to the trans-Golgi network, the PM and the ER [12]. In the ER, excess cellular cholesterol is esterified and stored in lipid droplets. These cholesteryl-ester stores can be activated in case of low cholesterol content.
In contrast to the cellular uptake of LDL, the delivery of HDL-derived cholesterol to cells is more complex and versatile. Selective uptake of cholesterol from HDL by scavenger receptor class B, type I (SR-BI) without catabolism of the lipoprotein particle is the major route of cholesterol delivery from HDL to cells [10]. In addition, HDL incorporates into lipid bilayers for direct cholesterol exchange [13]. Finally, endocytosis of HDL followed by lipid exchange and resecretion of the lipoprotein particle contributes to cellular cholesterol homeostasis [14, 15].

Canonical regulation of cholesterol homeostasis in the endoplasmic reticulum

Cellular cholesterol homeostasis is tightly regulated by cholesterol synthesis, uptake from lipoprotein particles and efflux to extracellular acceptors. Cholesterol can be synthetized in the ER from acetate [16]. The rate-limiting enzyme is hydroxymethylglutaryl-CoA reductase (HMG-CoAR), which is tightly regulated and catalyses an irreversible step, the synthesis of mevalonate. Mevalonate is further converted to squalene and then to lanosterol and finally, in mammals, to cholesterol. Newly synthesized cholesterol leaves the ER towards the plasma membrane either by vesicular transport along the secretory pathway or by non-vesicular transport, with the latter being the preferred mechanism [17, 18]. Importantly, HMG-CoAR is competitively inhibited by statins, the classical cholesterol-lowering drugs. Inhibition of cholesterol synthesis by statins leads to compensatory up-regulation of LDL-cholesterol import and consequently to lower plasma cholesterol levels.
Although the cholesterol content of the ER is very low, it is the main organelle for cholesterol level sensing and regulation. The transcription factor family sterol regulatory element binding proteins (SREBPs) are essentially involved in this regulation [19]. SREBPs in the ER are associated with Insulin-induced gene 1 protein (INSIG) and the SREBP cleavage activating protein (SCAP), which has a sterol-sensing domain. Decreasing cholesterol levels (below 5%) in the ER membrane lead to a conformational change of SCAP, which results in dissociation of INSIG1 from the complex [20]. The SREBP-SCAP complex can now leave the ER and is transported to the Golgi apparatus, where the proteases S1P and S2P release active SREBP, which translocates to the nucleus. Especially SREBP-2 controls cholesterol pathways [21], and target genes include HMG-CoAR, LDL-receptor and the HDL receptor SR-BI. Thus, decreasing ER cholesterol levels result in increased cholesterol synthesis and uptake regulated via SREBP2. Besides its physiological role as a sensor and modulator of cellular cholesterol metabolism, SREBP2 is implicated to play a pathophysiologically relevant role in a variety of disorders such as insulin resistance, pancreatic β‑cell toxicity, cognitive dysfunction and cancer [22]. For instance, SREBP2 is activated by low extracellular pH by an unknown mechanism. This might provide a growth advantage to cancer cells in the acidified tumour microenvironment [23]. Finally, SREBP2 is activated by ER stress, independent of cellular cholesterol level [24], as described in detail below (paragraph 4).
While SREBP2 prevent cells from insufficient cholesterol supply, a recent discovery identified a novel mechanism that prevents the ER from accumulation of excess cellular cholesterol [25]: the ER-bound transcription factor nuclear factor erythroid 2 related factor-1, Nfe2L1, often called NRF1. NRF1 directly binds cholesterol and thereby senses high cholesterol levels in the ER, leading to a de-repression of genes involved in cholesterol removal. This activation of cholesterol excretion is mediated by the liver X receptor (LXR). On the contrary, NRF1 deficiency leads to massive cholesterol accumulation in the liver. Similarly, oxysterols, which are formed in amounts proportional to cholesterol, regulate cholesterol homeostasis. Oxysterols are also ligands of NRF1, thereby mediating an LXR response. LXR itself forms heterodimers with the retinoid X receptor after activation and stimulates the expression of target genes [26]. Important target genes are the ATP binding cassette transporters (ABC) ABCA1 and ABCG1, which increase cholesterol efflux, and the inducible degrader of the LDL-receptor (IDOL), which down-regulates the LDL-receptor pathway [27]. Furthermore, the LXR pathway is a promising target for pharmacological activation to attenuate atherosclerotic plaque development [26], which is still limited because of adverse effects of available LXR agonists.

Deregulation of cholesterol homeostasis by endoplasmic reticulum stress

ER functions are not restricted to protein synthesis. Instead, the ER can be envisioned as a central sensor receiving systemic input from the whole organism. Especially metabolic syndrome and obesity pose a large burden, as elevated protein synthesis, high plasma levels of insulin and free fatty acid as well as systemic inflammation disturb ER homeostasis, leading to ER stress. Similarly, metabolic deregulation in cancer challenges the ER [2831]. In non-alcoholic fatty liver disease, a dysbalance of hepatic fatty acids causes ER stress [32]. Of note, also uptake of single meals composed of glucose or fat causes ER stress, indicating that transient loss of ER homeostasis is a physiologically relevant process [33]. However, chronically persistent ER stress—which is the case in metabolic disorders—leads to loss of metabolic control [34].
An elaborate signalling network, referred to as the “unfolded protein response” (UPR) enables adaption to ER stress or—if adaptive mechanisms fail—triggers apoptosis [35]. This signalling network is initiated by three effector proteins, ATF6, IRE1 and PERK, which mediate the activation of a transcriptional program with the aim to increase the ER folding capacity and reduce the protein folding burden of the ER by translational inhibition [35].
Two important discoveries particularly illustrate the interconnection between ER stress and cholesterol metabolism: First, ATF6 and SREBPs are cleaved by the very same proteases in the Golgi apparatus for subsequent translocation to the nucleus [36]. Second, ER stress and apoptosis are central mechanisms in cholesterol-mediated toxicity in macrophage foam cells [37] and therefore negatively affect the development of atherosclerosis. Relevant to atherosclerosis and metabolic disorder, homocysteine elevates cholesterol synthesis via an ER-stress-dependent mechanism [38]. Furthermore, activation of the UPR in hepatic cells decreases expression of ABCA1 [39]. Specifically, the PERK downstream target ATF4 is a regulator of ABCA1 expression [40]. Besides ABCA1, also SR-BI is repressed by the UPR [41]. These cholesterol transporters are involved in formation of HDL and the clearance of HDL-cholesterol from the bloodstream, respectively. This might negatively impact HDL’s reverse cholesterol transport capacity, resulting in peripheral cholesterol accumulation. In obese mice lacking the leptin receptor, over-expression of GRP78 increased biliary cholesterol excretion, indicating that ER dysfunction has an important role in the function of the biliary cholesterol transport proteins ABCG5 and ABCG8 [42]. This mechanism might further contribute to decreased RCT due to lower cholesterol excretion. In contrast, genetic disruption of the IRE1 signalling pathway lowers bile acid synthesis as well as plasma cholesterol levels, which suggests a positive role of the UPR on RCT [43]. Measuring RCT in vivo by monitoring the faecal excretion of cholesterol from cholesterol-loaded macrophages under conditions that interfere with the UPR would provide important insights into the question of how the UPR influences RCT. This would also clarify if chemical chaperones, which assist protein folding and antagonize the UPR in the liver [44], are therapeutically promising agents to counteract atherosclerosis.

Conflict of interest

C. Röhrl and H. Stangl declare that they have no competing interests.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
1.
Zurück zum Zitat Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10(2):109–21. CrossRefPubMed Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10(2):109–21. CrossRefPubMed
3.
Zurück zum Zitat Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol. 1985;1:1–39. CrossRefPubMed Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol. 1985;1:1–39. CrossRefPubMed
6.
Zurück zum Zitat Lippincott-Schwartz J, Phair RD. Lipids and cholesterol as regulators of traffic in the endomembrane system. Annu Rev Biophys. 2010;39:559–78. CrossRefPubMedPubMedCentral Lippincott-Schwartz J, Phair RD. Lipids and cholesterol as regulators of traffic in the endomembrane system. Annu Rev Biophys. 2010;39:559–78. CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Wustner D, Lund FW, Rohrl C, Stangl H. Potential of BODIPY-cholesterol for analysis of cholesterol transport and diffusion in living cells. Chem Phys Lipids. 2016;194:12–28. CrossRefPubMed Wustner D, Lund FW, Rohrl C, Stangl H. Potential of BODIPY-cholesterol for analysis of cholesterol transport and diffusion in living cells. Chem Phys Lipids. 2016;194:12–28. CrossRefPubMed
8.
Zurück zum Zitat Meißlitzer-Ruppitsch C, Röhrl C, Neumüller J, Pavelka M, Ellinger A. Photooxidation technology for correlated light and electron microscopy. J Microsc. 2009;235(3):322–35. CrossRefPubMed Meißlitzer-Ruppitsch C, Röhrl C, Neumüller J, Pavelka M, Ellinger A. Photooxidation technology for correlated light and electron microscopy. J Microsc. 2009;235(3):322–35. CrossRefPubMed
9.
Zurück zum Zitat Rohrl C, Meisslitzer-Ruppitsch C, Bittman R, Li Z, Pabst G, Prassl R, et al. Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particles. Curr Pharm Biotechnol. 2012;13(2):331–40. CrossRefPubMedPubMedCentral Rohrl C, Meisslitzer-Ruppitsch C, Bittman R, Li Z, Pabst G, Prassl R, et al. Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particles. Curr Pharm Biotechnol. 2012;13(2):331–40. CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(10):1732–8. CrossRefPubMed Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(10):1732–8. CrossRefPubMed
12.
Zurück zum Zitat Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125–38. CrossRefPubMed Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125–38. CrossRefPubMed
13.
Zurück zum Zitat Plochberger B, Rohrl C, Preiner J, Rankl C, Brameshuber M, Madl J, et al. HDL particles incorporate into lipid bilayers—a combined AFM and single molecule fluorescence microscopy study. Sci Rep. 2017;7(1):15886. CrossRefPubMedPubMedCentral Plochberger B, Rohrl C, Preiner J, Rankl C, Brameshuber M, Madl J, et al. HDL particles incorporate into lipid bilayers—a combined AFM and single molecule fluorescence microscopy study. Sci Rep. 2017;7(1):15886. CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Rohrl C, Pagler TA, Strobl W, Ellinger A, Neumuller J, Pavelka M, et al. Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cells. Histochem Cell Biol. 2010;133(3):261–72. CrossRefPubMed Rohrl C, Pagler TA, Strobl W, Ellinger A, Neumuller J, Pavelka M, et al. Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cells. Histochem Cell Biol. 2010;133(3):261–72. CrossRefPubMed
16.
Zurück zum Zitat Bloch K. Sterol molecule: structure, biosynthesis, and function. Steroids. 1992;57(8):378–83. CrossRefPubMed Bloch K. Sterol molecule: structure, biosynthesis, and function. Steroids. 1992;57(8):378–83. CrossRefPubMed
17.
Zurück zum Zitat Raychaudhuri S, Im YJ, Hurley JH, Prinz WA. Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein-related proteins and phosphoinositides. J Cell Biol. 2006;173(1):107–19. CrossRefPubMedPubMedCentral Raychaudhuri S, Im YJ, Hurley JH, Prinz WA. Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein-related proteins and phosphoinositides. J Cell Biol. 2006;173(1):107–19. CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, Ikonen E. Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci USA. 2000;97(15):8375–80. CrossRefPubMed Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, Ikonen E. Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci USA. 2000;97(15):8375–80. CrossRefPubMed
19.
Zurück zum Zitat Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89(3):331–40. CrossRefPubMed Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89(3):331–40. CrossRefPubMed
20.
Zurück zum Zitat Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008;8(6):512–21. CrossRefPubMedPubMedCentral Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008;8(6):512–21. CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–31. CrossRefPubMedPubMedCentral Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–31. CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710–30. CrossRefPubMed Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710–30. CrossRefPubMed
23.
Zurück zum Zitat Kondo A, Yamamoto S, Nakaki R, Shimamura T, Hamakubo T, Sakai J, et al. Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression. Cell Rep. 2017;18(9):2228–42. CrossRefPubMed Kondo A, Yamamoto S, Nakaki R, Shimamura T, Hamakubo T, Sakai J, et al. Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression. Cell Rep. 2017;18(9):2228–42. CrossRefPubMed
24.
Zurück zum Zitat Colgan SM, Tang D, Werstuck GH, Austin RC. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol. 2007;39(10):1843–51. CrossRefPubMed Colgan SM, Tang D, Werstuck GH, Austin RC. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol. 2007;39(10):1843–51. CrossRefPubMed
25.
Zurück zum Zitat Widenmaier SB, Snyder NA, Nguyen TB, Arduini A, Lee GY, Arruda AP, et al. NRF1 is an ER membrane sensor that is central to cholesterol homeostasis. Cell. 2017;171(5):1094–1109.e15. CrossRefPubMed Widenmaier SB, Snyder NA, Nguyen TB, Arduini A, Lee GY, Arruda AP, et al. NRF1 is an ER membrane sensor that is central to cholesterol homeostasis. Cell. 2017;171(5):1094–1109.e15. CrossRefPubMed
26.
Zurück zum Zitat Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(8):1513–8. CrossRefPubMed Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(8):1513–8. CrossRefPubMed
27.
Zurück zum Zitat Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 2009;325(5936):100–4. CrossRefPubMedPubMedCentral Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 2009;325(5936):100–4. CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 2008;29(1):42–61. CrossRefPubMed Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 2008;29(1):42–61. CrossRefPubMed
30.
Zurück zum Zitat Pagliassotti MJ, Kim PY, Estrada AL, Stewart CM, Gentile CL. Endoplasmic reticulum stress in obesity and obesity-related disorders: an expanded view. Metab Clin Exp. 2016;65(9):1238–46. CrossRefPubMedPubMedCentral Pagliassotti MJ, Kim PY, Estrada AL, Stewart CM, Gentile CL. Endoplasmic reticulum stress in obesity and obesity-related disorders: an expanded view. Metab Clin Exp. 2016;65(9):1238–46. CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Eigner K, Filik Y, Mark F, Schutz B, Klambauer G, Moriggl R, et al. The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone. Sci Rep. 2017;7(1):17498–17413. CrossRefPubMedPubMedCentral Eigner K, Filik Y, Mark F, Schutz B, Klambauer G, Moriggl R, et al. The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone. Sci Rep. 2017;7(1):17498–17413. CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Fuchs CD, Claudel T, Kumari P, Haemmerle G, Pollheimer MJ, Stojakovic T, et al. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology. 2012;56(1):270–80. CrossRefPubMed Fuchs CD, Claudel T, Kumari P, Haemmerle G, Pollheimer MJ, Stojakovic T, et al. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology. 2012;56(1):270–80. CrossRefPubMed
33.
Zurück zum Zitat Boden G, Song W, Duan X, Cheung P, Kresge K, Barrero C, et al. Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver. Obesity (Silver Spring). 2011;19(7):1366–73. CrossRef Boden G, Song W, Duan X, Cheung P, Kresge K, Barrero C, et al. Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver. Obesity (Silver Spring). 2011;19(7):1366–73. CrossRef
34.
Zurück zum Zitat Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012;15(5):623–34. CrossRefPubMed Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012;15(5):623–34. CrossRefPubMed
35.
Zurück zum Zitat Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081–6. CrossRefPubMed Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081–6. CrossRefPubMed
36.
Zurück zum Zitat Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2000;6(6):1355–64. CrossRefPubMed Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2000;6(6):1355–64. CrossRefPubMed
37.
Zurück zum Zitat Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5(9):781–92. CrossRefPubMed Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5(9):781–92. CrossRefPubMed
38.
Zurück zum Zitat Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107(10):1263–73. CrossRefPubMedPubMedCentral Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107(10):1263–73. CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Rohrl C, Eigner K, Winter K, Korbelius M, Obrowsky S, Kratky D, et al. Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells. J Lipid Res. 2014;55(1):94–103. CrossRefPubMedPubMedCentral Rohrl C, Eigner K, Winter K, Korbelius M, Obrowsky S, Kratky D, et al. Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells. J Lipid Res. 2014;55(1):94–103. CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Fusakio ME, Willy JA, Wang Y, Mirek ET, Al Baghdadi RJ, Adams CM, et al. Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver. Mol Biol Cell. 2016;27(9):1536–51. CrossRefPubMedPubMedCentral Fusakio ME, Willy JA, Wang Y, Mirek ET, Al Baghdadi RJ, Adams CM, et al. Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver. Mol Biol Cell. 2016;27(9):1536–51. CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Eberhart T, Eigner K, Filik Y, Fruhwurth S, Stangl H, Rohrl C. The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression. Biochem Biophys Res Commun. 2016;479(3):557–62. CrossRefPubMed Eberhart T, Eigner K, Filik Y, Fruhwurth S, Stangl H, Rohrl C. The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression. Biochem Biophys Res Commun. 2016;479(3):557–62. CrossRefPubMed
42.
Zurück zum Zitat Wang Y, Su K, Sabeva NS, Ji A, van der Westhuyzen DR, Foufelle F, et al. GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice. Metab Clin Exp. 2015;64(11):1435–43. CrossRefPubMedPubMedCentral Wang Y, Su K, Sabeva NS, Ji A, van der Westhuyzen DR, Foufelle F, et al. GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice. Metab Clin Exp. 2015;64(11):1435–43. CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Liu X, Henkel AS, LeCuyer BE, Hubchak SC, Schipma MJ, Zhang E, et al. Hepatic deletion of X‑box binding protein 1 impairs bile acid metabolism in mice. J Lipid Res. 2017;58(3):504–11. CrossRefPubMedPubMedCentral Liu X, Henkel AS, LeCuyer BE, Hubchak SC, Schipma MJ, Zhang E, et al. Hepatic deletion of X‑box binding protein 1 impairs bile acid metabolism in mice. J Lipid Res. 2017;58(3):504–11. CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313(5790):1137–40. CrossRefPubMedPubMedCentral Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313(5790):1137–40. CrossRefPubMedPubMedCentral
Metadaten
Titel
Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum
verfasst von
Clemens Röhrl
Herbert Stangl
Publikationsdatum
27.02.2018
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 11-12/2018
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-018-0626-2